Discordant effects of rasagiline doses  in Parkinson disease.
Deftereos
Spyros N
SN
Andronis
Christos A
CA
D004305:Dose-Response Relationship, Drug; D005987:Glyceraldehyde-3-Phosphate Dehydrogenases / Q000037:antagonists & inhibitors; D006801:Humans; D007189:Indans / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use*; D018696:Neuroprotective Agents / Q000008:administration & dosage* / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*
D007189:Indans; D018696:Neuroprotective Agents; C031967:rasagiline; D005987:Glyceraldehyde-3-Phosphate Dehydrogenases